Skip to content
Brand AI

Kashiv BioSciences

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2026

    Amneal Pharmaceuticals completes acquisition of Kashiv BioSciences

    Amneal Pharmaceuticals completed its acquisition of Kashiv BioSciences for up to $1.1 billion, creating a fully integrated global biosimilars platform. Terms included $375 million in cash, $375 million in equity at closing, and up to $350 million in additional milestone and contingent payments.

    Source